Hossein Hosseini

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Cardiovascular Risk Factors

Ejection Fraction

Top Venues

Phytotherapy research : PTR

BMC complementary medicine and therapies

This page only lists publications with an associated author ORCID identifier.

Publications

Abolfazl Karimivaselabadi, Mahmoud Osanloo, Ali Ghanbariasad, Elham Zarenezhad, Hossein Hosseini
Comparison of chitosan nanoparticles containing Lippia citriodora essential oil and citral on the induction of apoptosis in A375 melanoma cells. BMC complementary medicine and therapies 23 (1) (2023)
Hossein Hosseini, Farideh Ghavidel, Ghodratollah Panahi, Muhammed Majeed, Amirhossein Sahebkar
A systematic review and meta-analysis of randomized controlled trials investigating the effect of the curcumin and piperine combination on lipid profile in patients with metabolic syndrome and related disorders. Phytotherapy research : PTR 37 (3) (2023)
Hossein Hosseini, Farideh Ghavidel, Ghodratollah Panahi, Muhammed Majeed, Amirhossein Sahebkar
A systematic review and meta-analysis of randomized controlled trials investigating the effect of the curcumin and piperine combination on lipid profile in patients with metabolic syndrome and related disorders. Phytotherapy research : PTR 37 (3) (2023)
Hossein Hosseini, Farideh Ghavidel, Ghodratollah Panahi, Muhammed Majeed, Amirhossein Sahebkar
A systematic review and meta-analysis of randomized controlled trials investigating the effect of the curcumin and piperine combination on lipid profile in patients with metabolic syndrome and related disorders. Phytotherapy research : PTR (2023)
Hossein Hosseini, Farideh Ghavidel, Ghodratollah Panahi, Muhammed Majeed, Amirhossein Sahebkar
A systematic review and meta-analysis of randomized controlled trials investigating the effect of the curcumin and piperine combination on lipid profile in patients with metabolic syndrome and related disorders. Phytotherapy research : PTR 37 (3) (2023)